TBI research team finds associations between default mode network connectivity and emotion recognition and social integration
Tag: Clinical Trials
FOCUS may lower PE diagnosis in ED patients with suspected PE and abnormal vitals
DES PLAINES, IL — Focused cardiac ultrasound (FOCUS) performed by emergency physicians with advanced training in emergency ultrasound may significantly lower the likelihood of the diagnosis of pulmonary embolism (PE) in most patients who are suspected of PE and have…
Study finds association between physical activity, lower risk of fracture
Women who did the highest amount of physical activity had an 18% lower risk of hip fracture and 6% lower risk of total fracture
Wills Eye Hospital presents 4 inaugural awards at gala celebrating renowned retina service
Beloved, late retina surgeon is remembered, his family receives standing ovation as hospital leaders announce early outpouring of support with over 1 million dollars raised for research fund in his name
Liver-chip identifies drug toxicities in human, rat, and dog models
Species-specific liver-chip could improve success rate of drug candidates in clinical trials
Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.
US Innovation Program brings international entrepreneurs to Purdue
WEST LAFAYETTE, Ind. – The Purdue Research Foundation and the Purdue Foundry entrepreneurial community are helping to host a pair of entrepreneurs from Brazil and Uganda as part of the U.S. Department of State’s Global Innovation through Science and Technology…
Blood cancers: New generation stem cell transplant significantly reduces complications for patients
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the…
WVU’s RNI first in US to use deep brain stimulation to fight opioid addiction
MORGANTOWN, W.Va. – The West Virginia University Rockefeller Neuroscience Institute and WVU Medicine, today (Nov. 5) announced the launch of a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder. Funded through a grant…
Octapharma USA sponsors ASA Symposium on fibrinogen supplementation in surgical patients
JAMA publishes clinical study results comparing fibrinogen concentrate and cryoprecipitate in cardiac surgery
Updated Report on Trends in Global PD-1/PD-L1 Immunotherapy Clinical Development from the Cancer Research Institute Published in Nature Reviews Drug Discovery
Latest analysis of the global PD-1/PD-L1 immunotherapy clinical development pipeline reveals dramatic growth over past two years in number of trials, drug combinations, and drug targets, but lower patient recruitment rates in the U.S. compared to China.
Unique case of disease resistance reveals possible Alzheimer’s treatment
NIH-funded study identifies gene variant as potential drug target
Unique case of disease resistance reveals possible Alzheimer’s treatment
NIH-funded study identifies gene variant as potential drug target
SVIN’s 2019 Annual Meeting to highlight advances in stroke care worldwide
The Society of Vascular and Interventional Neurology (SVIN) is committed to improving stroke prevention strategies as well as expanding access to the most impactful and modern acute stroke treatments to our patients worldwide. Stroke and interventional neurologists who are members…
SVIN’s 2019 Annual Meeting to highlight advances in stroke care worldwide
The Society of Vascular and Interventional Neurology (SVIN) is committed to improving stroke prevention strategies as well as expanding access to the most impactful and modern acute stroke treatments to our patients worldwide. Stroke and interventional neurologists who are members…
ACP issues new guidance statement for colorectal cancer screening
Embargoed news from Annals of Internal Medicine
Unique case of disease resistance reveals possible Alzheimer’s treatment
NIH-funded study identifies gene variant as potential drug target
SVIN’s 2019 Annual Meeting to highlight advances in stroke care worldwide
The Society of Vascular and Interventional Neurology (SVIN) is committed to improving stroke prevention strategies as well as expanding access to the most impactful and modern acute stroke treatments to our patients worldwide. Stroke and interventional neurologists who are members…
ACP issues new guidance statement for colorectal cancer screening
Embargoed news from Annals of Internal Medicine
ACP issues new guidance statement for colorectal cancer screening
Embargoed news from Annals of Internal Medicine
Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials
November is national Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat “due to a mutational profile that makes it resistant to therapies that work better for other tumor types,” explains Angela Alistar, MD, medical director of GI oncology at Morristown Medical Center. Dr. Alistar, an internationally known expert on pancreatic cancer, is now enrolling patients in five clinical trials aimed at pancreatic cancer.
Obesity rates in China have tripled over the past 10 years
Embargoed news from Annals of Internal Medicine
AcuraStem triggers $3M phase II Fast Track SBIR Grant
The NINDS grant accelerates preclinical development of AcuraStem’s AS-1 Program for ALS
Researchers find risk factors for unemployment with multiple sclerosis vary by age
Kessler Foundation researchers studied relationships of multiple factors — age, disease, psychological, person-specific — with unemployment in individuals with multiple sclerosis
Could taking statins prevent dementia, disability?
NIH-funded clinical trial will test statins in 20,000 older adults
Influenza human challenge study begins at NIAID-sponsored clinical trial units
A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH’s National Institute of Allergy and Infectious Diseases (NIAID).…
Oncolytics Biotech® and PrECOG announce study in metastatic breast cancer
The BRACELET-1 (PrE0113) study seeks to confirm predictive and prognostic biomarkers demonstrating pelareorep can expand application of checkpoint inhibitors in HR+-metastatic breast cancer
Biogen to submit aducanumab results in early Alzheimer’s to US FDA
Alzheimer’s Association statement
In Alzheimer’s research, MIT scientists reveal brain rhythm role
In the years since her lab discovered that exposing Alzheimer’s disease model mice to light flickering at the frequency of a key brain rhythm could stem the disorder’s pathology, MIT neuroscientist Li-Huei Tsai and her team at The Picower Institute…
‘Brain in a dish’ models advance studies of neural development and disease
Questions remain about how well brain organoids mirror the complexity of the cortex
FMT is effective in IBS, but having a ‘super-donor’ is essential, new study finds
(Barcelona, October 21, 2019) The results of a large, randomised, double-blind, placebo-controlled study have confirmed that faecal microbiota transplantation (FMT) using a single ‘super-donor’ is an effective and well tolerated treatment for irritable bowel syndrome (IBS), producing high rates of…
NIH pairs cutting-edge neuroethics with ground-breaking neurotechnologies
NIH BRAIN Initiative collaboration looking at clinical research considerations
New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
2019 NCRI Cancer Conference, Glasgow, UK, Nov. 3-5
2019 NCRI Cancer Conference – the UK’s largest cancer conference is only a few weeks away. It will take place from Sunday 3 to Tuesday 5 November in Glasgow, UK. Registration for bona fide journalists is free. The Conference will…
EPFL is developing next-generation soft hearing implants
Close to half a million people around the world suffer from a serious hearing impairment. In some cases, they can find relief in cochlear and other types of implants. Yet these devices do not help people whose inner ear is…
Listening to ‘noisy knees’ to diagnose osteoarthritis: The first human cohort study
A new way of diagnosing and assessing knee osteoarthritis (OA) has moved a step closer with a major study paving the way for its use in research and clinical practice. The technique involves attaching small microphones to knees, and detecting…
First study to test healthy lifestyle changes in reducing the risk of dementia in a large-scale, diverse population in the United States
A new study at Rush University Medical Center aims to determine whether a combination of lifestyle changes can protect memory and thinking skills in people at risk of developing dementia. The two-year U.S. Study to Protect Brain Health Through Lifestyle…
MSU and Spectrum Health researchers team up to find new treatments for ‘orphan diseases’
These understudied disorders afflict up to 25 million Americans
Women get half the number of heart attack treatments as men
New blood test diagnoses more women with heart attack but gender gap in treatment remains
C-Path, CDISC develop standard to represent data for Animal Rule studies
TUCSON, Ariz. and AUSTIN, Texas, October 15, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Foundational Standard that describes how to represent data for the natural history and efficacy studies…
MAP Congress 2019: Interpreting molecular alterations for clinical practice
Molecular Analysis for Personalised therapy (MAP) Congress, London, UK, 7-9 November 2019
Global trial is first clear evidence that widely available drug reduces head injury deaths
Early treatment with tranexamic acid could save ‘hundreds of thousands of lives worldwide’
Clinical research improves health of UK economy and NHS
Findings show clinical research “adds billions to the economy, boosts jobs and generates much needed income for the NHS” according to Chief Executive Jonathan Sheffield New KPMG analysis shows that clinical trials supported by the NIHR Clinical Research Network contribute…
The New York Stem Cell Foundation Annual Conference
The New York Stem Cell Foundation’s (NYSCF) 14th Annual Conference convenes global leaders in stem cell research to present their latest progress towards new treatments and cures for the most devastating diseases and injuries in the world.
Hyperfine and Yale School of Medicine collaborate on world’s first portable MRI technology
Guilford, CT, October 14, 2019 — Hyperfine Research Inc. announced today its collaboration with the Yale School of Medicine to pioneer the use of the world’s first portable, low-cost magnetic resonance imaging (MRI) system at the bedside of patients in…
Overcoming the blood-brain-barrier: Delivering therapeutics to the brain
For the first time, scientists have identified a simple way that can effectively transport medication into the brain – which could lead to improved treatments for neurological and neurodegenerative diseases. In a study published today in Nature Communications , scientists…
Rare sleep disorder common among veterans with PTSD
Findings may provide insight about development of neurodegenerative conditions like Parkinson’s disease
Lung cancer screening guidelines do not detect disease among first responders
Research presented at IASLC 2019 North America Conference on Lung Cancer
Using mindfulness as a tool to help fight the opioid crisis
Boston Medical Center awarded multi-million dollar grant as a part of NIH HEAL initiative
Type 2 diabetes and obesity could be treated by new, less invasive procedure
New research from King’s College London published in EBioMedicine , has found that a newly tested medical device, called Sleeveballoon, mimics the effects of traditional bariatric surgery in rodents and produces impressive results on body weight, fatty liver and diabetes…